Article Archive For Keyword:
and its
AUTHOR: David PennDATE: JUL 2001
Akamai Technologies And Its Believable Breakout
ARTICLE SYNOPSIS...Some breakouts work right away, others fail miserably, and still others simply take their sweet time, driving action-hungry traders crazy. The new break higher in Akamai Technologies looks like one that may get going very soon.
AUTHOR: Donald W. Pendergast, Jr.DATE: SEP 2010
AUTHOR: Donald W. Pendergast, Jr.DATE: SEP 2011
AUTHOR: Chaitali MohileDATE: JUN 2011
AUTHOR: Donald W. Pendergast, Jr.DATE: MAR 2009
AUTHOR: Donald W. Pendergast, Jr.DATE: JAN 2013
AUTHOR: Koos van der MerweDATE: FEB 2011
Nasdaq And Its Cycle: Is There A Joker In The Pack?
ARTICLE SYNOPSIS...Last week I discussed the Dow and its cycle, the week before, the S&P 100 index and its cycle. This week I am looking at the Nasdaq index, its cycle and other technical tools.
AUTHOR: Koos van der MerweDATE: AUG 2003
Paper Money And Its Promises
ARTICLE SYNOPSIS...Long-term charts of the dollar, bonds, crude oil, and gold help set the table for investors and speculators in 2006. Part 1 of two.
AUTHOR: David PennDATE: APR 2006
AUTHOR: Koos van der MerweDATE: SEP 2003
AUTHOR: Donald W. Pendergast, Jr.DATE: NOV 2012
AUTHOR: Koos van der MerweDATE: AUG 2003
The EU Ratings War And Its Repercussions
ARTICLE SYNOPSIS...Several credit agencies have been rattling their sabers over the EU debt crisis but in the end, who will be the winners or losers and, more important, how do you profit?
AUTHOR: Billy WilliamsDATE: DEC 2011
AUTHOR: Koos van der MerweDATE: SEP 2003
VRDN And Its Reverse Stock Splits
ARTICLE SYNOPSIS...Viridian Therapeutics, Inc. (VRDN) is a small cap biopharmaceutical company which engages in the development of proprietary RNA targeted therapeutics. Since its Initial Public Offering in June 2014, the company has reduced the number of its shares throug
AUTHOR: Stella Osoba, CMTDATE: AUG 2024
Working Money: Paper Money And Its Promises by David Penn
AUTHOR: David PennDATE: JUL 2006